MAB-22

· Xentria, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MAB-22, covering 2025-05-11 to 2025-07-29. Get the full timeline:

Most recent: Clinical Trial Update: Single Dose, Three-arm Study to Compare the Pharmacokinetic Similarity of MAB-22 Versus Prolia® [Phase 1]